Follow The Filings

CAH Cardinal Health

Health Care, filed as CARDINAL HEALTH INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 3 managers in 2026 Q2, sold by 1

  • 2 Owners
  • #223
  • Max 0.9%
  • Master 0.00%
  • $2.5M
  • 1 reduce

In 2026 Q3 Murphy Pohlad trimmed Cardinal Health.

Who owns this now

Largest portfolio weights among holders, up to 0.9% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Reduce 0.86%
  2. Kentucky Trust Co. 0.01%

Who owns CAH

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.86%, was 0.92% Reduce −0.1% 11,099 $2.5M History
Kentucky Trust Co., Kentucky Trust 0.01% Hold 117 $26K History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CAH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CAH insider trades
  • None no insider bought on the open market
  • $61.6M sold by 8 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Mary C. Scherer Chief Accounting Officer
    Sale
    $546K 2,302 shares at $237.39 45% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  2. Michelle D. Greene Chief Information Officer
    Sale
    $2.7M 11,650 shares at $235.72 53% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  3. Deborah Weitzman CEO, PSS Segment
    Sale
    $1.7M 7,354 shares at $235.45 8.6% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  4. Stephen M Mason CEO, GMPD Segment
    Sale
    $8.3M 35,000 shares at $236.40 66% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  5. Jessica L Mayer Chief Legal/Compliance Officer
    Sale
    $7M 29,436 shares at $236.19 47% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  6. Aaron E Alt CFO
    Sale
    $9.9M 42,000 shares at $236.34 67% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  7. Jason M. Hollar CEO
    Sale
    $29.4M 124,529 shares at $235.89 40% of stake
    Traded Aug 18–19 Filed Aug 20
    ↗
  8. Michelle D. Greene Chief Information Officer
    Sale
    $627K 2,746 shares at $228.47 18% of stake
    Traded Feb 27 Filed Mar 3
    ↗
  9. Aaron E Alt CFO
    Sale
    $525K 2,328 shares at $225.50 8.1% of stake
    Traded Feb 18 Filed Feb 18
    ↗
  10. Patricia Hemingway Hall Director
    Sale
    $919K 4,000 shares at $229.72 12% of stake
    Traded Feb 6 Filed Feb 10
    ↗

Also filed in the last 12 months, not counted as buying or selling: 29 stock grants and 14 share withholdings for taxes.

Congress

5 members of Congress traded CAH in the last three years: 11 buys and 1 sale. 5 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Marjorie Taylor Greene R-GA-14 Buy $1K–$15K Oct 24, 2025 filed Oct 28, 2025
  3. Marjorie Taylor Greene R-GA-14 Buy $1K–$15K May 14, 2025 filed May 19, 2025
  4. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Apr 8, 2025 filed May 8, 2025
  5. Marjorie Taylor Greene R-GA-14 Buy $1K–$15K May 5, 2025 filed May 6, 2025
  6. Marjorie Taylor Greene R-GA-14 Buy $1K–$15K Mar 17, 2025 filed Mar 19, 2025

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,1.02,2.03,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $205.01B $226.83B $222.58B $254.25B
Gross profit $6.89B $7.41B $8.17B $9.77B
Gross margin * 3.4% 3.3% 3.7% 3.8%
Net income $0.261B $0.852B $1.56B $1.71B
Net margin * 0.1% 0.4% 0.7% 0.7%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $33.83B $34.88B $36.37B $38.75B
Total non-current assets * $9.58B $10.24B $16.75B $18.55B
Total assets $43.42B $45.12B $53.12B $57.3B
Total current liabilities $33.71B $35.64B $38.9B $43.9B
Total equity -$2.85B -$3.21B -$2.78B -$2.88B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $2.84B $3.76B $2.4B $5.17B
Cash from investing -$0.454B -$1.85B -$5.59B -$2.58B
Cash from financing -$3.05B -$0.847B $1.94B -$1.6B
Net change in cash -$0.674B $1.06B -$1.26B $0.982B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.